Literature DB >> 651653

Initial splanchnic extraction of ingested glucose in normal man.

J Radziuk, T J McDonald, D Rubenstein, J Dupre.   

Abstract

Estimates of initial splanchnic uptake of ingested glucose and the concomitant suppression of endogenous glucose production were obtained in man by validated tracer techniques for non--steady-state turnover measurement. Nine normal volunteers (18--44 yr old) fasted overnight received intravenous infusions of tracer (3-3H-glucose or 1-14C-glucose) and a low (45 +/- 1 g) or high (96 +/- 5 g) oral load of glucose labeled with an alternative tracer (1-14C-glucose or 2-2H-glucose). A two-compartment model was used to derive rates of peripheral appearance (Ra) of glucose from all sources (total) and the Ra of ingested glucose. Ra (total glucose) and Ra (ingested glucose) were integrated from the first appearance of ingested glucose until the basal Ra (total glucose) or 116 +/- 6 (SEM) mg/min was reattained. The total amount of glucose reaching the systemic pool in this time was 95 +/- 4 g and 46 +/- 3 g with high and low doses, respectively. Of these quantities 86 +/- 4 g and 40 +/- 3 g originated in the oral glucose, representing 90% +/- 4% of the administered glucose. The remainder (11% +/- 2% of the total) represented endogenous production, suppressed by 66% +/- 6% relative to basal. Sequestration of ingested glucose and subsequent release did not take place during the study since identical results were obtained with ingested 1-14C-glucose or 2-3H-glucose. The latter label would have been lost if the glucose had entered the hexose--phosphate pool. Thus, in normal man approximately 90% of an ingested glucose load is absorbed and passes through the liver to appear in the systemic pool.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 651653     DOI: 10.1016/0026-0495(78)90003-3

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  39 in total

1.  Effect of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding on gastrointestinal metabolism of ingested glucose.

Authors:  Faidon Magkos; David Bradley; J Christopher Eagon; Bruce W Patterson; Samuel Klein
Journal:  Am J Clin Nutr       Date:  2015-11-25       Impact factor: 7.045

2.  Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour?

Authors:  J Radziuk; S Pye
Journal:  Diabetologia       Date:  2006-05-16       Impact factor: 10.122

3.  A fuzzy model of glucose regulation.

Authors:  Em Ward; Terry Martin
Journal:  J Med Syst       Date:  2006-06       Impact factor: 4.460

4.  Absorption patterns of meals containing complex carbohydrates in type 1 diabetes.

Authors:  D Elleri; J M Allen; J Harris; K Kumareswaran; M Nodale; L Leelarathna; C L Acerini; A Haidar; M E Wilinska; N Jackson; A M Umpleby; M L Evans; D B Dunger; R Hovorka
Journal:  Diabetologia       Date:  2013-02-23       Impact factor: 10.122

Review 5.  The biochemistry of diabetes.

Authors:  R Taylor; L Agius
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

Review 6.  The physiological basis of insulin treatment--clinical aspects.

Authors:  W K Waldhäusl
Journal:  Diabetologia       Date:  1986-12       Impact factor: 10.122

7.  First-pass hepatic uptake and utilization of glucose in the rat.

Authors:  M Muratoglu; J Kuyumjian; N Kalant
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

8.  Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy.

Authors:  G Pehling; P Tessari; J E Gerich; M W Haymond; F J Service; R A Rizza
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

9.  Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal.

Authors:  Dan Zheng; Viorica Ionut; Vahe Mooradian; Darko Stefanovski; Richard N Bergman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

Review 10.  Clinical islet cell transplantation. Are we there yet?

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1998-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.